These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 76453)

  • 1. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied.
    Snider GL; Celli BR; Goldstein RH; O'Brien JJ; Lucey EC
    Am Rev Respir Dis; 1978 Feb; 117(2):289-97. PubMed ID: 76453
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of mechanical properties to parallel changes in lung connective tissue composition in bleomycin-induced pulmonary fibrosis in hamsters.
    Goldstein RH; Lucey EC; Franzblau C; Snider GL
    Am Rev Respir Dis; 1979 Jul; 120(1):67-73. PubMed ID: 88916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology.
    Snider GL; Hayes JA; Korthy AL
    Am Rev Respir Dis; 1978 Jun; 117(6):1099-108. PubMed ID: 78675
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Aminopropionitrile prevents bleomycin-induced pulmonary fibrosis in the hamster.
    Riley DJ; Kerr JS; Berg RA; Ianni BD; Pietra GG; Edelman NH; Prockop DJ
    Am Rev Respir Dis; 1982 Jan; 125(1):67-73. PubMed ID: 6175260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of oxygen toxicity after lung injury by bleomycin in hamsters.
    Rinaldo J; Goldstein RH; Snider GL
    Am Rev Respir Dis; 1982 Dec; 126(6):1030-3. PubMed ID: 6185022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary vitamin E supplement does not inhibit changes in lung pressure-volume characteristics produced by bleomycin in hamsters.
    Sato S; Nakamura H; Takada K; Takahashi K
    Eur Respir J; 1988 Jun; 1(6):523-6. PubMed ID: 2458962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function in interstitial lung diseases in children.
    Gaultier C; Chaussain M; Boulé M; Buvry A; Allaire Y; Perret L; Girard F
    Bull Eur Physiopathol Respir; 1980; 16(1):57-66. PubMed ID: 7357127
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis.
    Borzone G; Moreno R; Urrea R; Meneses M; Oyarzún M; Lisboa C
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1648-53. PubMed ID: 11401889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung elasticity in regional and diffuse pulmonary fibrosis.
    Fine R; McCullough B; Collins JF; Johanson WG
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Jul; 47(1):138-44. PubMed ID: 89110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
    Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
    Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine pulmonary function tests during bleomycin therapy. Tests may be ineffective and potentially misleading.
    Lewis BM; Izbicki R
    JAMA; 1980 Jan; 243(4):347-51. PubMed ID: 6153225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of tomographic findings with pulmonary function parameters in nonsmoking patients with idiopathic pulmonary fibrosis].
    Lopes AJ; Capone D; Mogami R; Cunha DL; Melo PL; Jansen JM
    J Bras Pneumol; 2007; 33(6):671-8. PubMed ID: 18200367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis.
    Hughes JM; Lockwood DN; Jones HA; Clark RJ
    Respir Physiol; 1991 Feb; 83(2):155-66. PubMed ID: 2068413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of lung diffusing capacity for nitric oxide in systemic sclerosis.
    Barisione G; Garlaschi A; Occhipinti M; Baroffio M; Pistolesi M; Brusasco V
    Physiol Rep; 2019 Aug; 7(13):e14149. PubMed ID: 31264386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of alpha-difluoromethylornithine on the development of bleomycin-induced pulmonary fibrosis in hamsters.
    Giri SN; Hyde DM; Schwartz LW; Younker WR
    Am J Pathol; 1982 Oct; 109(1):115-22. PubMed ID: 6181691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of the static compliance and carbon monoxide diffusion capacity in the verification of a pulmonary fibrosis associated with silicoses].
    Mährlein W
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 135(2):217-24. PubMed ID: 5211696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of vitamin E deficiency on bleomycin-induced pulmonary fibrosis in hamsters].
    Nakamura H; Sato S; Takahashi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):539-47. PubMed ID: 2444734
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise.
    Sue DY; Oren A; Hansen JE; Wasserman K
    N Engl J Med; 1987 May; 316(21):1301-6. PubMed ID: 3574401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic correlations in lymphoid interstitial pneumonia.
    Collie DD; Warren PM; Begara I; Luján L; Watt NJ
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1575-82. PubMed ID: 8004316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on lung compliance, lung volume, and single-breath transfer factor for carbon monoxide in sheep with lentivirus-induced lymphoid interstitial pneumonia.
    Collie DD; Watt NJ; Warren PM; Begara I; Luján L
    Am J Vet Res; 1993 Mar; 54(3):454-62. PubMed ID: 8388674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.